CC
Corton Capital Portfolio holdings
AUM
$85.9M
1-Year Return
50.75%
This Quarter Return
-8.73%
1 Year Return
+50.75%
3 Year Return
+186.03%
5 Year Return
–
10 Year Return
–
AUM
$231M
AUM Growth
+$5.66M
(+2.5%)
Cap. Flow
+$46.7M
Cap. Flow
% of AUM
20.2%
Top 10 Holdings %
Top 10 Hldgs %
29.12%
Holding
515
New
301
Increased
21
Reduced
100
Closed
92
Top Buys
| 1 |
Airbnb
ABNB
|
$2.17M |
| 2 |
Tesla
TSLA
|
$2.12M |
| 3 |
Snowflake
SNOW
|
$1.95M |
| 4 |
Phillips 66
PSX
|
$1.52M |
| 5 |
Thermo Fisher Scientific
TMO
|
$1.31M |
Top Sells
| 1 |
Occidental Petroleum
OXY
|
$2.52M |
| 2 |
APA Corp
APA
|
$1.85M |
| 3 |
Alcoa
AA
|
$1.43M |
| 4 |
Starbucks
SBUX
|
$1.4M |
| 5 |
ConocoPhillips
COP
|
$1.36M |
Sector Composition
| 1 | Technology | 38.45% |
| 2 | Healthcare | 13.99% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Energy | 8.37% |
| 5 | Industrials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Cue Biopharma
CUE
$60.7M
| $68K | 0.03% |
+13,925
| New | +$68K |
|
402
Viant Technology
DSP
$165M
| $68K | 0.03% |
+10,378
| New | +$68K |
|
403
The GEO Group
GEO
$2.98B
| $68K | 0.03% |
10,269
-44,042
| -81% | -$292K |
|
404
Nuvation Bio
NUVB
$1.31B
| $67K | 0.03% |
+12,760
| New | +$67K |
|
405
Vor Biopharma
VOR
$252M
| $65K | 0.03% |
+10,795
| New | +$65K |
|
406
NextCure
NXTC
$13M
| $62K | 0.03% |
+1,055
| New | +$62K |
|
|
CHS
407
DELISTED
Chicos FAS, Inc.
CHS
| $60K | 0.03% |
+12,555
| New | +$60K |
|
408
Vroom, Inc. Common Stock
VRM
$141M
| $60K | 0.03% |
+283
| New | +$60K |
|
409
CytomX Therapeutics
CTMX
$351M
| $57K | 0.02% |
+21,209
| New | +$57K |
|
|
AGEN
410
Agenus
AGEN
$138M
| $56K | 0.02% |
+1,155
| New | +$56K |
|
411
Oric Pharmaceuticals
ORIC
$1.08B
| $56K | 0.02% |
10,501
-6,411
| -38% | -$34.2K |
|
412
Conduent
CNDT
$452M
| $53K | 0.02% |
10,338
-44,975
| -81% | -$231K |
|
|
GRTS
413
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $53K | 0.02% |
12,852
-8,449
| -40% | -$34.8K |
|
|
STKL
414
SunOpta
STKL
$769M
| $52K | 0.02% |
+10,399
| New | +$52K |
|
|
SURF
415
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $52K | 0.02% |
+17,586
| New | +$52K |
|
|
INZY
416
DELISTED
Inozyme Pharma
INZY
| $46K | 0.02% |
+11,350
| New | +$46K |
|
|
VLDR
417
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $43K | 0.02% |
+16,603
| New | +$43K |
|
418
Compugen
CGEN
$132M
| $41K | 0.02% |
+12,783
| New | +$41K |
|
419
Viking Therapeutics
VKTX
$2.99B
| $40K | 0.02% |
+13,269
| New | +$40K |
|
420
BeyondSpring
BYSI
$75.4M
| $39K | 0.02% |
+17,583
| New | +$39K |
|
421
Precision BioSciences
DTIL
$58.8M
| $39K | 0.02% |
+420
| New | +$39K |
|
422
Dianthus Therapeutics
DNTH
$815M
| $35K | 0.02% |
+759
| New | +$35K |
|
423
Ribbon Communications
RBBN
$719M
| $32K | 0.01% |
+10,474
| New | +$32K |
|
424
Acco Brands
ACCO
$371M
| – | – |
-24,450
| Closed | -$202K |
|
425
AdaptHealth
AHCO
$1.27B
| – | – |
-12,124
| Closed | -$297K |
|